Search Results 81-90 of 16759 for alt

  1. Biliary atresia - Diagnosis and treatment - Mayo Clinic

    Mildly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), which are liver enzymes. Matrix metalloproteinase-7 (MMP7) testing.

  2. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

    Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ... ALT (≤ 2.5 x ULN) = ______; ULN = ______. Serum phosphate < institutional ...

  3. Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis - Mayo Clinic

    ALT ≥ 5 × ULN: If a third serum ALT measurement is required, and both Screening Visit 2 and unscheduled visit ALT values are ≥ 0% higher than the ...

  4. A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor - Mayo Clinic

    ... [ALT]) =< 135. U/L - Note: For the purpose of this study, the ULN for SGPT (ALT) has been set to the value of 45 U/L - The patient must be able to undergo ...

  5. Impact of CardiolRxTM on Recurrent Pericarditis - Mayo Clinic

    Elevated alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 times the upper limit of normal (ULN) or ALT or AST >3x ULN plus bilirubin >2x ...

  6. Study of rSIFN-co for Patients with Advanced Solid Tumors - Mayo Clinic

    ... ALT > 1 x ULN, and HBV DNA >2000 IU/ml), or hepatitis C (defined as ALT > 1 x ULN, persistent viremia on antiviral therapy) infections; Has a history of ...

  7. PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes - Mayo Clinic

    ALT (SGPT) < 2 times upper limit of normal; Alkaline phosphatase < 2 times upper limit of normal; Triglycerides < 150 mg/dl (except for Aim 4). Aim 4. Age 30 ...

  8. Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma - Mayo Clinic

    ... ALT is 45 U/L; If the lab abnormality is thought to be due to the lymphoma the patient is eligible and dose adjustments should be made; Shortening fraction of ...

  9. A Multicenter Open Label Trial Using Ambrisentan in Patients with Porto-pulmonary Hypertension - Mayo Clinic

    Moribund state or anticipated death within 1 month. AST or ALT ≥ 5 times upper limit of normal; Total bilirubin ≥ 3.0 mg/dl; Significant lung disease ...

  10. Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA - Mayo Clinic

    Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) =< 1.5 x institutional ULN; Alkaline phosphatase =< 1.5 x institutional ULN; Serum ...